UK Markets close in 6 hrs 57 mins
  • FTSE 100

    5,631.30
    -97.69 (-1.71%)
     
  • FTSE 250

    17,347.67
    -240.04 (-1.36%)
     
  • AIM

    963.01
    -9.52 (-0.98%)
     
  • GBP/EUR

    1.1042
    -0.0019 (-0.17%)
     
  • GBP/USD

    1.2974
    -0.0067 (-0.5138%)
     
  • BTC-GBP

    10,516.54
    -4.42 (-0.04%)
     
  • CMC Crypto 200

    268.89
    +7.60 (+2.91%)
     
  • S&P 500

    3,390.68
    -10.29 (-0.30%)
     
  • DOW

    27,463.19
    -222.21 (-0.80%)
     
  • CRUDE OIL

    38.02
    -1.55 (-3.92%)
     
  • GOLD FUTURES

    1,903.00
    -8.90 (-0.47%)
     
  • NIKKEI 225

    23,418.51
    -75.79 (-0.32%)
     
  • HANG SENG

    24,708.80
    -78.39 (-0.32%)
     
  • DAX

    11,729.76
    -333.81 (-2.77%)
     
  • CAC 40

    4,606.14
    -124.52 (-2.63%)
     

Global Immunosuppressant Drugs Market Report 2019-2020 & 2028: Focus on Corticosteroids, Monoclonal Antibodies, Calcineurin Inhibitors, Mtor Inhibitors

Research and Markets
·4-min read

Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Immunosuppressant Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

The global immunosuppressant drugs market is expected to display a positive market trend over the forecast period of 2019-2028, exhibiting a CAGR of 4.00%.

The growing demand for organ transplantation and the rise in the number of autoimmune disorders are the primary factors fueling the growth of this market. A malfunctioning of the immune system results in it attacking the healthy cells, tissues, and organs. Thus, immunosuppressants are used in this case to weaken the immune system. Furthermore, there is a huge demand for these drugs from growing countries. Also, the exports of drugs and medicine around the world are on the rise.

However, immunosuppressant drugs cause side-effects, which is negatively affecting their demand. This is a major restraining factor for market growth. Besides, the lack of awareness about organ donation is creating hurdles in the path of market growth.

REGIONAL OUTLOOK

The global market for immunosuppressant drugs covers the regions of North America, Latin America, the Asia-Pacific, Europe, and the Middle East and Africa.

Latin America is expected to be the fastest-growing region in the global market over the forecast period. Its pharmaceutical industry is thriving. Brazil has been dominating the region in the last few decades, which is attributable to its large population; however, Mexico is expected to surpass the country soon.

The other major markets in the region are Argentina, Columbia, and Venezuela. With the booming populations, an increase in healthcare spending, and double-digit market growth, the markets in Latin America are proving to be attractive and rewarding for the global pharma industry. A growth in this industry implies a growth in the demand for immunosuppressant drugs as well. This is fueling the regional market's growth.

COMPETITIVE OUTLOOK

The eminent companies in this market are Bristol-Myers Squibb Company, GlaxoSmithKline plc, F Hoffmann-La Roche Ltd, Pfizer Inc, Mylan NV, Dr Reddys Laboratories Ltd, Abbvie Inc, Astellas Pharma Inc, Cipla Ltd, Veloxis Pharmaceuticals Inc, Allergan (acquired by Abbvie Inc), Sanofi, Intas Pharmaceuticals Ltd (Accord Healthcare), Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), and Novartis AG.

GlaxoSmithKline is a global leader in the field of pharmaceutical and consumer health-related products. It primarily operates in North America, Europe, and the Asia-Pacific. It has an employee strength of over 100000 people. Benlysta (belimumab) is an immunosuppressive drug offered by the company. GSK is among the world's most prominent prescription pharmaceutical companies, and enjoys major benefits due to its global footprint.

Key Topics Covered:

1. Global Immunosuppressant Drugs Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Organ Transplantation Leads the Market by End-User
2.2.2. Pharmaceutical Industry Showing Growth Trends
2.2.3. Impact of Covid 19 on Transplant Recipients
2.3. Evolution & Transition of Immunosuppressant Drugs
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Demand from Organ Transplantation
2.7.2. Rise in the Number of Autoimmune Disorders
2.8. Market Restraints
2.8.1. Side Effects of Immunosuppressant Drugs
2.9. Market Opportunities
2.9.1. Demand from Emerging Economies
2.9.2. Exports of Drugs and Medicine Worldwide on Rise
2.10. Market Challenges
2.10.1. Lack of Awareness About Organ Donation

3. Global Immunosuppressant Drugs Market Outlook - by Drug Class
3.1. Corticosteroids
3.2. Monoclonal Antibodies
3.3. Calcineurin Inhibitors
3.4. Mtor Inhibitors
3.5. Others

4. Global Immunosuppressant Drugs Market Outlook - by Distribution Channel
4.1. Hospital Pharmacies
4.2. Retail Pharmacies
4.3. Online Pharmacies

5. Global Immunosuppressant Drugs Market Outlook - by End-User
5.1. Organ Transplantation
5.2. Autoimmune Disorders
5.3. Others

6. Global Immunosuppressant Drugs Market - Regional Outlook

7. Competitive Landscape
7.1. Abbvie Inc
7.2. Allergan (Acquired by Abbvie Inc)
7.3. Astellas Pharma Inc
7.4. Bristol-Myers Squibb Company
7.5. Cipla Ltd
7.6. Dr Reddys Laboratories Ltd
7.7. F Hoffmann-La Roche Ltd
7.8. GlaxoSmithKline plc
7.9. Intas Pharmaceuticals Ltd (Accord Healthcare)
7.10. Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
7.11. Mylan Nv
7.12. Novartis AG
7.13. Pfizer Inc
7.14. Sanofi
7.15. Veloxis Pharmaceuticals Inc

8. Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/2am2ai

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900